Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

Conditions:   Advanced Cancer;   Advanced Malignancies;   Bladder Cancer;   Cervical Cancer;   Esophageal Cancer;   Gastric Cancer;   Gastroesophageal-junction Cancer (GEJ);   Head and Neck Squamous Cell Carcinoma (HNSCC);   Non-Small Cell Lung Cancer (NSCLC);   Ovarian Cancer;   Renal Cell Carcinoma (RCC);   Triple Negative Breast Cancer (TNBC) Interventions:   Drug: AB598;   Drug: Zimberelimab;   Drug: Carboplatin;   Drug: Pemetrexed;   Drug: Fluorouracil;   Drug: Leucovorin;   Drug: Oxaliplatin Sponsor:   Arcus Biosciences, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials